Diabetes Type II Clinical Trial
Official title:
A Pilot Study of the Effects of Diet and Behavioral Interventions on Health in Diabetics
The study is a small pilot, designed to provide data regarding the feasibility and acceptability of conducting such a study on a larger scale. The present study is a randomized controlled clinical trial comparing two mindfulness-based lifestyle modification programs to help people manage diabetes and lose weight, one using on a low-carbohydrate diet (LC) and the other using a moderate-carbohydrate diet promoted by the American Diabetes Association (ADA). Intervention content will include information about nutrition (carbohydrate restriction or American Diabetes Association recommended diet) and emotion regulation and mindful eating strategies.
Approximately 40 individuals with Type II diabetes or prediabetes will be randomized in a 1:1 ratio to treatment groups. Groups will meet for 12 weekly sessions, then approximately biweekly for 3 sessions, for a total of 15 1.5-2 hour sessions over 4.5 months. Participants will be evaluated at 0, 1 month, 3 months, and 6 months. Our outcome of interest is HbA1c (glycated hemoglobin, a measure indicative of blood glucose levels and tied to diabetes severity). ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01121315 -
A Retrospective Study of Cardiovascular Events Related to the Use of Glucose Lowering Drug Treatment in Primary Care
|
N/A | |
| Completed |
NCT02773095 -
Evaluation of Novartis Access; a Non-communicable Disease (NCD) Access Initiative
|
N/A | |
| Completed |
NCT02184455 -
Feasibility Study of DermGEN for Diabetic Foot Ulcer Treatment
|
Phase 1 | |
| Recruiting |
NCT02361489 -
Clinical Study to Compare Various Dosing and Titration Guidelines of Insulin Delivered Via V-Go ® in Patients With Type 2 Diabetes Initiating Basal Bolus Therapy in Primary Care Offices
|
Phase 4 | |
| Completed |
NCT02326129 -
Novel Biomarker for Development of T2D
|
||
| Not yet recruiting |
NCT02074540 -
The Influence of Health Beliefs and Uncertainty on Diabetes Type II Patient Compliance
|
N/A |